9 September 2020 - During the coronavirus surge in Texas this summer, Dr. Thomas Patterson said he only had enough of the anti-viral drug remdesivir for about a third of his patients, and was forced to pick and choose who would get the only drug authorised in the United States to treat COVID-19.
Meanwhile, Dr. Ahmedul Kabir in Bangladesh has plenty.